Horweiz Pharmaceutical Private Limited
About Horweiz Pharmaceutical Private Limited
Data last updated:
Horweiz Pharmaceutical Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U33119MP2018PTC046755. Its GSTIN is 23AAECH6697M1ZZ (Madhya Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Mukesh Mehta and Akash Rathore Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 291 Satyadev Nagar Scheme No. 97, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹93.34 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹73,681 (net margin 0.8%) and EBITDA of ₹1.72 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 42% over five years.
Company details
Contact details
Horweiz Pharmaceutical Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address291 Satyadev Nagar Scheme No. 97, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Horweiz Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Horweiz Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Horweiz Pharmaceutical Private Limited, buy the company report.
Financials of Horweiz Pharmaceutical Private Limited
FY 2025 filings availableHorweiz Pharmaceutical Private Limited reported revenue of ₹93.34 Lakh (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 42% over five years, including 17% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹73,681 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Horweiz Pharmaceutical Private Limited, buy the company report.
Board of directors of Horweiz Pharmaceutical Private Limited
Horweiz Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Mehta | Director | 18 Jul 2019 | 7 Years 3 Months | Current |
| Akash Rathore Kumar | Director | 30 Sep 2018 | 8 Years 1 Months | Current |
| Bhupendra Singh Rathore | Director | 30 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Horweiz Pharmaceutical Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alive Lifecare Private Limited | ₹93.88 Lakh (FY 2025) | 112420.0% | Nagpur, Maharashtra, India | |||
| Healogics Pharmaceuticals Private Limited | ₹93.51 Lakh (FY 2025) | -17.0% | Patna, Bihar, India | |||
| Horweiz Pharmaceutical Private Limitedthis company | ₹93.34 Lakh (FY 2025) | ₹73,681 | 0.8% | 17.0% | Indore, Madhya Pradesh, India | |
| Aquila Life Sciences Private Limited | ₹93.1 Lakh (FY 2025) | -22.0% | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Horweiz Pharmaceutical Private Limited, buy the company report.
Auditor
Horweiz Pharmaceutical Private Limited is audited by N M RATHI & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N M RATHI & ASSOCIATES | FY 2019 | 013578C |
Shareholding
The shareholding of Horweiz Pharmaceutical Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Horweiz Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Horweiz Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Horweiz Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Horweiz Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAECH6697M1ZZ | Madhya Pradesh | Active | 19 Nov 2018 |
To see the full GST registrations and return filing status of Horweiz Pharmaceutical Private Limited, buy the company report.
Recent activity
Horweiz Pharmaceutical Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Mukesh Mehta was appointed as Director on 18 Jul 2019.
Frequently asked questions
Horweiz Pharmaceutical is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 September 2018 (8+ years old) and is registered under CIN U33119MP2018PTC046755.
Horweiz Pharmaceutical has 3 current directors:
- Mukesh Mehta - Director
- Akash Rathore Kumar - Director
- Bhupendra Singh Rathore - Director
The latest financial statements of Horweiz Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Horweiz Pharmaceutical is 23AAECH6697M1ZZ, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Horweiz Pharmaceutical is U33119MP2018PTC046755. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Horweiz Pharmaceutical was incorporated on 30 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Horweiz Pharmaceutical by revenue are Alive Lifecare Private Limited, Healogics Pharmaceuticals Private Limited, Aquila Life Sciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Mukesh Mehta was appointed as Director on 18 Jul 2019. Akash Rathore Kumar was appointed as Director on 30 Sep 2018. Bhupendra Singh Rathore was appointed as Director on 30 Sep 2018.
The registered office of Horweiz Pharmaceutical is at 291 Satyadev Nagar Scheme No. 97, Indore, Madhya Pradesh, India – 452001.
Horweiz Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Horweiz Pharmaceutical can be reached at its registered office: 291 Satyadev Nagar Scheme No. 97, Indore, Madhya Pradesh, India – 452001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
